-
740 Y-P: PI 3-Kinase Activator Workflows
2026-09-17
Use 740 Y-P as a cell-permeable positive perturbation to connect PI3K/AKT signaling with vesicular trafficking, neuronal cell survival, and cancer-cell phenotypes. This workflow-focused guide covers dosing, controls, assay selection, and troubleshooting for reproducible in vitro experiments.
-
PD 173074: Reproducible FGFR1 Assays
2026-09-16
This scenario-driven guide explains how PD 173074 (SKU A8253) can improve experimental interpretation in FGFR1, VEGFR2, viability, proliferation, and cytotoxicity workflows. It covers mechanism, solvent compatibility, dose selection, data interpretation, and practical supplier evaluation using documented potency and formulation information.
-
DOTAP and the Translational Logic of RNA Delivery
2026-09-15
A mechanistic and strategic guide to using 1,2-Dioleoyl-3-trimethylammonium-propane chloride for nucleic acid delivery, while translating lessons from self-amplifying Nppa RNA and lipid nanoparticle research into more rigorous cardiovascular workflows.
-
M344: A Practical Histone Deacetylase Inhibitor Guide
2026-09-15
M344 is a cell-permeable epigenetic tool for connecting histone acetylation with proliferation, differentiation, apoptosis, migration, and treatment response. This workflow-focused guide shows how to design dose–time screens, validate mechanism, compare tumor models, and troubleshoot solubility or toxicity artifacts.
-
Estradiol, ER Stress, and CD4+ T Cells After Shock
2026-09-14
The reference study shows that hemorrhagic shock impairs splenic CD4+ T-lymphocyte proliferation and cytokine production while activating endoplasmic reticulum stress. Pharmacological experiments indicate that 17β-estradiol restores these immune functions mainly through ERα and GPR30-associated suppression of ER stress, rather than through ERβ.
-
PBA-Targeted PAD4 Inhibitors Block NET-Driven Tumors
2026-09-14
The reference study develops phenylboronic acid (PBA)-modified PAD4 inhibitors to concentrate activity in tumors while suppressing the PAD4–H3cit–NET pathway in neutrophils. Its lead compound, 5i, reduced tumor growth and lung metastasis in mouse models, providing a targeting strategy that may improve the therapeutic selectivity of PAD4 inhibition.
-
Aurora A Overexpression in High-Risk Retinoblastoma
2026-09-13
A 2024 American Journal of Pathology study links elevated Aurora kinase A (AURKA) expression with histopathologic high-risk features in retinoblastoma and validates AURKA dependence through genetic, pharmacologic, cellular, and xenograft models. The findings connect AURKA activity with MYCN regulation and support further investigation of Aurora A-directed strategies in chemotherapy-refractory disease.
-
Heparin Sodium as a Mechanistic Assay Tool
2026-09-12
Heparin sodium is more than a standard glycosaminoglycan anticoagulant: it can help researchers design cleaner coagulation and glycocalyx-perturbation experiments. This article connects heparin mechanism, assay controls, and plant-derived nanovesicle research without overstating evidence across domains.
-
Nystatin (Fungicidin) Research Workflows
2026-09-12
Build more reproducible Candida growth, adhesion, biofilm, and combination assays with an ergosterol-targeting polyene. This guide pairs practical formulation controls with emerging evidence on liposomal Nystatin for Aspergillus infection and ergosterol-directed synergy.
-
CUDC-907 Protocol and QC Guide
2026-09-11
CUDC-907 (SKU A4097) is a dual PI3K and HDAC inhibitor for coordinated studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis in cancer cell models. It is intended for controlled scientific research workflows only and should not be used for diagnostic, therapeutic, or clinical applications.
-
Berberine, RXRα/PPARγ/NEDD4, and Atherosclerosis
2026-09-11
This 2025 study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-related inflammation in atherosclerotic foam cells. Its combination of mouse, cellular, transcriptomic, and macrophage-specific knockdown experiments provides a useful framework for testing how nuclear-receptor signaling controls inflammatory aging in plaques.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-09-10
The PKH26 Red Fluorescent Cell Linker Kit (SKU K2410) provides membrane-associated red fluorescence for tracking labeled cells and monitoring signal partitioning during proliferation. It is intended for cell membrane lipid region fluorescent labeling in vitro or in vivo, not for intracellular targets or non-membrane labeling.
-
Arrb2, 6-ketoLCA, and Hepatic Ischemia–Reperfusion Injury
2026-09-10
The reference study identifies hepatocyte β-arrestin 2 (Arrb2) as a regulator of hepatocyte–macrophage communication during hepatic ischemia–reperfusion injury, linking Arrb2 expression to increased 6-ketoLCA and M2 macrophage polarization. Its combination of clinical association, hepatocyte-selective mouse genetics, hypoxia–reoxygenation experiments, and metabolite analysis provides a mechanistic framework for studying immunometabolic control of liver injury.
-
Ionizing Radiation and Altered Neuronal Differentiation
2026-09-09
The reference study shows that ionizing radiation does more than reduce neural stem-cell survival: it drives an altered neuronal differentiation program in C17.2 cells through PI3K-linked STAT3–mGluR1 and p53 signaling. Its combination of morphology, neuronal markers, function-related genes, pathway inhibition, and primary-cell validation provides a useful framework for studying radiation-associated neural dysfunction.
-
Sodium chloride: Buffer and Cell Culture Guide
2026-09-09
Sodium chloride is an inorganic salt used to control ionic strength and osmotic balance in buffer preparation, cell culture media, and related biochemical workflows. This guide covers practical handling and QC boundaries; prepare solutions in water, use them promptly, and do not select DMSO or ethanol as solvents.